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Introduction
Sporotrichosis is a chronic mycosis caused by fungi of 
the genus Sporothrix.1,2 The traditional route of transmis-
sion in humans and animals is by traumatic inoculation 
of contaminated material (eg, soil and decaying organic 
matter) into subcutaneous tissues.3 Alternative routes 
include direct transmission (cat-to-cat and cat-to-human) 
through scratching and biting,4 and human inhalation of 
infectious conidia.3,4
Sporotrichosis is an emerging zoonotic disease that is 
most prevalent in Latin America5 but has spread world-
wide.3 Species within the Sporothrix schenckii complex 
(Sporothrix brasiliensis, Sporothrix globosa, Sporothrix 
schenckii sensu stricto and Sporothrix luriei) make up the 
clinical clade of the Sporothrix genus that most commonly 
affects humans and animals.3,6 S brasiliensis is the main 
causative agent of feline sporotrichosis. In contrast, the 
species within the Sporothrix pallida complex (Sporothrix 
mexicana, Sporothrix chilensis, Sporothrix palmicuminata, 
Sporothrix humicola, Sporothrix pallida and Sporothrix sty­
lites) are rarely pathogenic and are usually self-resolving. 
There have only been four published case reports attrib-
uted to S pallida complex: two in humans,7,8 one in a cat 
and one in two eastern quolls (both recent reports from 
First case report of cutaneous 
sporotrichosis (Sporothrix species) 
in a cat in the UK
Nikoleta Makri1 , Gavin K Paterson2, Fiona Gregge3, 
Catriona Urquhart4 and Tim Nuttall1
Abstract
Case summary A 12-year-old female neutered indoor–outdoor domestic longhair cat presented with frequent 
sneezing and a nodular, suppurative lesion on its dorsal nose. Histopathological examination revealed a fungal 
granuloma. PCR and sequencing of the ribosomal internal transcribed spacers (ITS) regions (ITS-F and ITS-R) 
confirmed an infection with a Sporothrix species. Further sequencing of the beta-tubulin and calmodulin genes 
confirmed Sporothrix humicola, which lies within the Sporothrix pallida complex. The cat had concurrent diabetes 
mellitus, which responded to insulin therapy and diet. Oral itraconazole at 10 mg/kg PO q24h resulted in resolution 
of the lesions after 12 months. Treatment was well tolerated.
Relevance and novel information This is the first report of sporotrichosis in a cat in the UK and only the fifth 
worldwide involving the S pallida complex. Clinicians, pathologists and microbiologists need to be aware of the 
potential of Sporothrix infections in the UK and the ability of S pallida complex to cause opportunistic infections. 
Molecular techniques can achieve rapid and accurate identification of rare fungal organisms. A precise diagnosis 
with molecular testing can provide information regarding prognosis, treatment and zoonotic implications.
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Australia).9,10 In this case report, we describe the first con-
firmed case of feline sporotrichosis in the UK. This was 
attributed to a species within the S pallida complex.
Case description
A 12-year-old client-owned indoor–outdoor, vaccinated, 
female neutered domestic longhair cat was initially pre-
sented with a history of a nodular lesion on its dorsal 
nose, frequent sneezing and intermittent bilateral sero-
sanguinous nasal discharge. The nodule was hard on 
palpation, non-ulcerative and non-painful (Figure 1). 
According to the owner, this had developed acutely. 
There was no history of previous injury and general 
physical examination (including regional lymph node 
palpation) was unremarkable. Initially, the cat was 
treated empirically by the referring veterinarian with 
amoxicillin–clavulanate (25 mg/kg PO q12h) and predni-
solone (0.8 mg/kg PO q24h), but there was no significant 
improvement of the clinical signs. Thus, haematology 
and routine serum biochemistry were performed, which 
showed increased alanine aminotransferase (139 U/l; ref-
erence interval [RI] 18–77 U/l) and alkaline phosphatase 
(91 U/l; RI 11–67 U/l) with hyperglycaemia (21.1 mmol/l; 
RI 3.80–7.6 mmol/l). Further serum fructosamine testing 
(597 µmol/l; RI: 221–341 µmol/l) confirmed a diagnosis 
of diabetes mellitus and the cat was started on subcutane-
ous insulin therapy (Caninsulin 40 IU/ml initially started 
at 2 IU q12h and finally stabilised at 3.5 IU q12h). Thoracic 
and head radiographs showed soft tissue swelling with-
out bone lysis on the nasal region, but there were no 
abnormalities detected in the chest.
Fresh nasal discharge was collected for cytological, 
bacterial and mycological analysis. The lesion was surgi-
cally debulked and nasal tissue was submitted for histo-
pathology. Postoperative analgesia was achieved with 
meloxicam 0.05 mg/kg PO q24h. Cytology revealed pyo-
granulomatous inflammation with numerous basophilic 
round-to-oval yeasts surrounded by a thin clear halo 
(Figure 2). Histopathology of the skin revealed diffuse 
infiltration of macrophages together with smaller 
numbers of neutrophils, lymphocytes and plasma cells. 
Spherical-to-oval fungal elements were observed within 
macrophages (confirmed with periodic acid–Schiff stain-
ing). Bacterial culture was negative.
A white mould-like growth was seen after overnight 
incubation at room temperature and at 37oC on 
Sabouraud dextrose agar with chloramphenicol. Long, 
delicate conidiophores were seen on microscopy. The 
isolate was classified phenotypically as a Trichosporon 
species using the YST identification card on an auto-
mated VITEK 2 analyser (Biomerieux). However, 
sequencing of the ribosomal internal transcribed spac-
ers (ITS) with the primers ITS-1 and ITS-4, identified the 
isolate as being a Sporothrix species.11 Sequencing of the 
calmodulin and beta-tubulin genes using primer pairs 
CAL-Fw and CAL-Rv and Bt2a and Bt2b, respectively, 
was used to further identify the isolate.12,13 Using these 
partial gene sequences, the best matches in NCBI Blast 
searches limited to type material were to S humicola in 
both cases. The partial calmodulin gene sequence 
matched 100% to that of S humicola CBS 118129 (corre-
sponding to nucleotide positions 1–564 of Genbank 
Figure 1 (a) The cat shortly after presentation with a large suppurative nodule on its dorsal nose (the sutures were used  
to close the incisional biopsy site). (b) Complete resolution of the cutaneous lesions with only residual scarring at the biopsy 
site after 12 months of itraconazole treatment (10 mg/kg PO q24h)
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accession KX590808.1) and the partial beta-tubulin gene 
sequence matched 98.2% with that of S humicola 
CMW7618 (=CBS 118129, corresponding to nucleo tide 
positions 1–292 of Genbank accession EF139100.1).
Treatment with itraconazole (10 mg/kg PO q24h) was 
started. The lesion gradually regressed and was com-
pletely resolved with only some scar tissue present at the 
biopsy site after 12 months of treatment (Figure 1). The 
itraconazole was well tolerated by the cat, with no reported 
side effects. The diabetes mellitus remained stable with 
low-calorie/high-fibre diets and insulin therapy.
Discussion
This is the first confirmed case of feline sporotrichosis in 
the UK. It was attributed to S humicola, which is a species 
within the S pallida complex. Sporothrix species can cause 
cutaneous and disseminated mycoses in humans, cats 
and other animals, although most infections are associ-
ated with species in the S schenckii complex.3 S brasiliensis 
accounts for most feline cases and epidemic outbreaks 
have been reported.3,14 Studies in experimental mouse 
models, in contrast, show that the S pallida complex is 
much less pathogenic.15 Naturally occurring infections 
are rare and sporadic.3 The affected cat had typical clini-
cal signs of localised nodular and ulcerative fungal infec-
tion of the face, with no evidence of disseminated 
disease. It is therefore likely that the infection was associ-
ated with a penetrating trauma or a cat scratch.
The clinical severity of sporotrichosis varies from 
asymptomatic and self-resolving to extensive and dis-
seminated, depending on the route of transmission, the 
Sporothrix species and the host immune response.3 Most 
feline lesions are limited to areas that contact soil and/or 
are common sites of injury such as the nose, ears and 
digits.3 In contrast to humans, lymphatic involvement is 
rare in cats,16 but unusual presentations such as otitis 
externa have been described in cats and dogs.17–19
This cat’s underlying diabetes mellitus is likely to have 
made it more susceptible to infection. The cat had not been 
tested for other causes of being immunocompromised 
(owing to owner’s considerable financial constraints), 
such as feline leukaemia virus or feline immunodeficiency 
virus, and these cannot be entirely ruled out. Opportunistic 
fungal pathogens have to overcome the host’s immune 
response to cause disease, and immunocompromised cats 
are more susceptible.3 Identifying and managing under-
lying conditions is therefore important.
A rapid and accurate diagnosis of an opportunistic 
fungal infection can be challenging. Cytology is a quick 
and easy test; as in this case, it should reveal pyogranu-
lomatous inflammation.3 Fungal elements may be visi-
ble, but their absence cannot be used to rule out a fungal 
infection and, conversely, their presence may simply 
reflect environmental contamination.20,21 Histopathology 
typically confirms pyogranulomatous inflammation.22 
Round-to-oval yeasts and hyphae are seen in most cases, 
especially if fungal-specific stains are used, but cases of 
sporotrichosis without histopathological evidence of the 
fungi have been reported.23 In addition, the cytological 
and histopathological appearance of Sporothrix species 
can be variable and resemble other fungal organisms.20–22 
Further diagnostics are therefore required for a defini-
tive diagnosis.
Fungal culture is the gold standard for an accurate 
diagnosis of sporotrichosis.5 However, this relies on 
clinicians considering fungal infection as a differential 
Figure 2 Indirect impression smear cytology of the cutaneous lesion showing oval encapsulated bodies (a), some of which 
have been phagocytosed by macrophages (b) (Rapi-Diff II stain, × 400 magnification)
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diagnosis for these lesions and submitting material for 
fungal culture. In addition, it can take up to 2–4 weeks to 
report samples as negative. Finally, relying on morpho-
logical characteristics of the fungal elements and bio-
chemical tests may, as in this case, incorrectly identify 
the organism.
Molecular methods offer a precise diagnosis for fun-
gal infections. This aids appropriate treatment choices, 
prognostic predictions and zoonotic risk assessments. 
In this case, a sequential approach after initial fungal 
culture was used. PCR and sequencing of the ribosomal 
ITS regions is the standard approach to fungal identifi-
cation. This confirmed an infection with a Sporothrix 
species but did not allow confident speciation. Further 
sequencing of the beta-tubulin and calmodulin genes 
confirmed that the isolate lay within the S pallida com-
plex and identified it as S humicola.24 A more rapid diag-
nosis could be achieved by applying these molecular 
techniques directly to fresh tissue. However, these sen-
sitive techniques can amplify contaminants and other 
tests (eg, cytology and histopathology) should also be 
used to confirm the infection.
Treatment of sporotrichosis can be challenging. The 
traditional treatment in cats is oral administration of an 
imidazole or triazole antifungal, with or without potas-
sium iodide.3,25,26 Continuation of treatment for at least 
30 days after clinical cure is essential to reduce the 
chances of recurrence. Itraconazole and potassium 
iodine are commonly used, although potassium iodide 
has a high incidence of side effects in cats (particularly 
iodism).
The prognosis will depend on diagnosis and man-
agement of any underlying problems.10,26 In this case, 
accurate identification of infection with an S pallida 
complex isolate of low pathogenicity and zoonotic risk 
suggested a fair prognosis with itraconazole treatment. 
In addition, the good response of the diabetes mellitus 
to insulin therapy contributed to the successful resolu-
tion. It is difficult to determine the relative roles of the 
antifungal treatment and management of the diabetes 
mellitus in this case. It is possible that the infection 
could have resolved with management of the diabetes 
mellitus alone, but treatment of opportunist fungal 
infections is recommended.27 The prolonged course of 
itraconazole was well tolerated, although this can be 
associated with gastrointestinal disease and hepato-
pathy, and thus liver enzymes should be regularly 
monitored.3,26
Conclusions
Sporothrix species are found worldwide, although infec-
tions are most common in subtropical and tropical cli-
mates. To our knowledge, this is the first confirmed case 
of feline sporotrichosis in UK and only the fifth report 
worldwide of an infection with the S pallida complex, 
which is considered a low pathogenic clade of Sporothrix 
species. This should therefore be considered as a cause of 
nodular and other pyogranulomatous lesions, especially 
in immunocompromised individuals. Molecular tech-
niques can be used to rapidly and accurately identify 
fungal agents, facilitating treatment, prognosis and 
zoonotic considerations.
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